HotSpur launches dialysis technology with new $2.75M
HotSpur Technologies, developer of technology for less invasive dialysis, has brought in $2.75 million to bring its two lead products to market. Based in Mountain View, Calif., the company is backed by Onset Ventures, Bio-Star Private Equity Fund, Finistere Partners, Saratoga Ventures, Three Arch Partners… Continue Reading
Satiety fills up on $25.3M for obesity treatments
Satiety, maker of a minimally-invasive medical device that reduces obesity, has raised $25.3 million of an anticipated $33 million round of equity and rights, according to a filing with the SEC. The Palo Alto, Calif. company was previously backed by HLM Venture Partners, Morgenthaler Ventures,… Continue Reading
Satiety secures $7.5M bridge for tummy tuck shortcut
Satiety, maker of a minimally-invasive device that shrinks stomach capacity via the mouth, has landed a $7.5 million bridge loan from its existing investors — a group that includes Skyline Ventures, HLM Venture Partners, Pinnacle Ventures, Morgenthaler Ventures, Three Arch Partners, Venrock and medical inventor… Continue Reading
SpinalMotion stacks up $500K for fake spinal discs
Artificial spinal disc producer SpinalMotion, just tacked $500,000 onto its $20 million third round of funding through a patent licensing agreement with an unnamed corporation. Based in Mountain View, Calif., the company makes both cervical and lumbar artificial discs that are still undergoing clinical trials…. Continue Reading
Allux Medical shuts down, turns to Sherwood
Silicon Valley shutdown/turnaround consultancy Sherwood Partners has been called in by ailing Allux Medical, a Menlo Park, Calif.-based developer of devices used to treat airway and skin inflammatory diseases. The company, which managed to raise $13 million in capital and a $1.68 million bridge round,… Continue Reading
Arete nabs $16.7M more to treat metabolic disorders
Biotech company Arete Therapeutics brought in $16.7 million in the final tranche of a first round of funding that now totals $51 million. The Hayward, Calif.-based company will use the money to push its lead treatment for metabolic syndrome through a second phase of clinical… Continue Reading
Nevro raises $22 million for pain therapy
Nevro Corp. has raised $22 million in a first round of funding. The Palo Alto, Calif. company is conducting clinical trials for its neuromodulation therapy for chronic pain. New investor Accuitive Medical Ventures joined return investors Aberdare Ventures, Bay City Capital, Mayo Clinic, MPM Capital… Continue Reading
New $32M round helps APT battle lung transplant rejection
APT Pharmaceuticals Inc. announced today that it has raised $32 million in its second round from a flock of investors led by Three Arch Partners, and including InterWest Partners, Pinnacle Ventures, Charter Life Sciences, Great Point Partners, Versant Ventures and Vivo Ventures.
APT, headquartered in Burlingame,… Continue Reading
Spinal device developer Baxano raises $20M
Baxano, a startup in stealth mode that’s developing a spinal medical device, has raised $20 million in a second round of funding, according to VentureWire. The round was led by new backer Kearny Venture Partners, with participation from existing investors Prospect Venture Partners and Three… Continue Reading
Voyage Medical raises $22M for heart treatment
Voyage Medical, which is developing new treatment for a heart condition called atrial fibrillation, has raised $22 million in a second round of financing. New investor Three Arch Partners led the round, with participation from Kleiner Perkins Caulfield & Byers (also a new investor) and… Continue Reading
Novasys Medical takes $49.5M for women’s medical device
Novasys Medical is a Newark, Calif. medical company that makes a device for a specific condition affecting some women, called female stress urinary incontinence.
The device Novasys makes is the only real alternative to surgery for women with the problem, according to an interview with the… Continue Reading
Life-science briefing: Tuesday, March 25, 2008
TODAY’S HEADLINES:
Antibody-discovery startup Adimab raises new funding (release)
Lung-device maker Spiration gets $19M (release)
Sample-prep startup Protein Discovery pulls in $10M (release)
Inogen takes in $13M for portable oxygen device (VentureWire)
Healthcare IT concern Medaptus raises $11M for expansion (VentureWire)
Contract lab Synexis raises $14M (peHUB)
Medical-device VC firm BioStar Ventures takes… Continue Reading
Life sciences briefing: Monday, Jan. 7, 2008
TODAY’S HEADLINES:
Surgical-device maker Aragon Surgical receives $25M (release)
Tacere Therapeutics strikes RNAi deal with Pfizer for up to $145M (release)
Benvenue Medical raises $15M for spine-repair devices (release)
Genome-association co. Genizon BioSciences draws C$31M (release)
Contract research organization Inclinix pulls in $10M (release)
EPocrates, healthcare IT developer, gets strategic investment… Continue Reading
Life sciences briefing: Wednesday, Oct. 17, 2007
Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer
UPDATE: Expanded TriReme Medical, Ikonisys and TranS1 items.
UPDATE REDUX: Added MicroPhage item.
Stent-maker TriReme… Continue Reading
VisionCare’s implantable microtelescope — a bionic eye for AMD-related blindness
An implantable and odd-looking microtelescope from a Saratoga, Calif., device maker could be one of the next big things in treating a common form of blindness — assuming that patients are willing to endure arduous surgery in order to obtain their new bionic eyes.
Age-related macular… Continue Reading
Life sciences briefing: Tuesday, Aug. 14, 2007
Featured companies: Tenaxis Medical, Aspen MedTech, Biolex Therapeutics
Tenaxis closes up $5M for surgical sealants — Mountain View, Calif.-based Tenaxis Medical, a developer of glues and sealants for closing surgical incisions, raised $5 million in a second funding round, VentureWire reports (subscription required). Individual investors, including several… Continue Reading
Satiety pulls in $30M for obesity device
Satiety, a Palo Alto, Calif., device maker focused on obesity, raised $30 million in a fourth round of funding. Skyline Ventures led the round, joined by HLM Venture Partners, Pinnacle Ventures, Venrock, Three Arch Partners, Morgenthaler Ventures and Thomas Fogarty.
Satiety is developing a minimally invasive… Continue Reading
Arete raises $35M for cardiovascular treatments
Arete Therapeutics, a Hayward, Calif., developer of biotech cardiovascular treatments, raised a $35 million extension to its first round of funding. Founded in 2003, the company is working on “small molecule” drugs that target a metabolism-related chain of biochemical cellular signals that involves arachidonic acid…. Continue Reading
NeuroVista raises $33.8M for epilepsy devices
(CORRECTED: See below.)
Seattle-based NeuroVista, a developer of devices for the treatment of epilepsy, raised $33.8 million in a second-round funding and left behind its former name, BioNeuronics.
The company, founded in 2002 by whiz kid Daniel DiLorenzo, has been quiet about its technology and commercial direction. In… Continue Reading
Pegasus Bio gets $20M for surgical-repair bioimplants
Pegasus Biologics, an Irvine, Calif., maker of flexible-but-strong tissue substitutes designed to speed muscle-tendon repair or wound healing, raised $20 million in a third round of funding.
Despite the word “biologics” in its name — a term that is often synonymous with protein-based biotechnology drugs —… Continue Reading